RxDoctor Payments Data

Casmir Ezim

Podiatrist · Bakersfield, CANPI 1841710381

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Organogenesis Inc. at 54.1% of the total. Reporting peaked in 2023 at $7,728 and has fallen 56.3% since, to $3,375 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,001in general payments, 2019–2025

Across 279 payments — averaging $75.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$11K
  • Smith+Nephew$4K
  • Smoky Mountain Surgical LLC$1K
  • Medical Device Business Services, Inc.$639
  • Stryker$554
  • Arthrex$442
  • plus $2K from 31 others

What the payments were for

  • Speaking & faculty fees$8,90142%
  • Travel & lodging$4,26620%
  • Food & beverage$7,81837%
  • Education$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,001 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$181,154
Medicare patients
305
Services billed
1,752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole66$1,221
Ciclopirox32$859
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip23$614
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$555
Methylprednisolone40$338
Ciprofloxacin Hcl18$235
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$195
Doxycycline Hyclate18$165
Terbinafine Hcl18$147
Tramadol Hcl14$61
Meloxicam26$51

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →